Shuoming M. Luo
Key Laboratory Of Diabetes Immunology
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Disease-modifying therapies for type 1 diabetes: current landscape and future perspectives
Journal: Zhonghua nei ke za zhi
Published: August 05, 2026
HLA-guided identification of monogenic diabetes in antibody-negative type 1 diabetes: frequency and characteristics.
Journal: Diabetes & metabolism
Published: November 16, 2025
The Role of HLA Class II Two-Locus Haplotypes and Genotypes in Chinese With Type 1 Diabetes.
Journal: Diabetes/metabolism research and reviews
Published: February 07, 2025
Differences in Immune Cell-Derived Circular RNA Between Fulminant Type 1 Diabetes and Type 1 Diabetes.
Journal: Diabetes/metabolism research and reviews
Published: February 12, 2024
Hsa_circRNA_405498 and hsa_circRNA_100033 Serve as Potential Biomarkers for Differential Diagnosis of Type 1 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 22, 2023
Effect of SIRT1 gene single-nucleotide polymorphisms on susceptibility to type 1 diabetes in a Han Chinese population.
Journal: Journal of endocrinological investigation
Published: July 08, 2023
Fulminant type 1 diabetes: Focusing on triggering factors.
Journal: Diabetes/metabolism research and reviews
Published: June 20, 2023
Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials.
Journal: Diabetes/metabolism research and reviews
Published: June 02, 2023
Plasma-derived exosomal miRNA profiles associated with type 1 diabetes.
Journal: Diabetes/metabolism research and reviews
Published: May 24, 2023
Clinical characteristics of immune checkpoint inhibitor-related type 1 diabetes mellitus
Journal: Zhonghua yi xue za zhi
Published: January 03, 2023
Last Updated: 09/26/2026